U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Vaccines, Blood & Biologics
  3. Vaccines
  4. BEXSERO
  1. Vaccines

BEXSERO

STN: BL 125546
Proper Name: Meningococcal Group B Vaccine
Trade Name: BEXSERO
Manufacture: GlaxoSmithKline Biologicals SA
Indication:

  • For active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. BEXSERO is approved for use in individuals aged 10 through 25 years.

Product Information

Supporting Documents

Back to Top